Hongbin Yang

Hongbin Yang


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2020 in The Patient - Patient-Centered Outcomes Research
Verified
Journal Article
Closed access
PDF file
XZXueyun Zeng
Xueyun Zeng
MSMingjie Sui
Mingjie Sui
BLBo Liu
Bo Liu
HYHongbin Yang
Hongbin Yang
RLRui Liu
Rui Liu
NLNan Luo
Nan Luo

3 October 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
HYHongjuan Yu
Hongjuan Yu
HZHuan Zhang
Huan Zhang
JYJinjin Yang
Jinjin Yang
Chaojie LiuChaojie Liu
Chaojie Liu
CLChengfang Lu
Chengfang Lu
LLLi-min Li
Li-min Li
This study assessed the health related quality of life of family caregivers (FCs) of leukemia patients by using the health utility scores derived from the EuroQol five-dimensional (EQ-5D) questionnaire. A cross-sectional survey was undertaken on 306 family caregivers of leukemia patients to assess their health utility using the EQ-5D-3L. Participants were recruited from three hospitals in China’s Heilongjiang province. The health utility scores of the participants were estimated based on the Chinese EQ-5D-3L value set and compared with those of the local general population. Factors predicting the health utility scores were identified through the Kruskal-Wallis analysis of variance and median regression analyses. FCs had lower health utility scores than the general population (p < 0.001). The participants with a lower socioeconomic status had lower utility scores and reported more problems than those with a higher socio-economic status. Better family function and higher social support were associated with higher health utility scores. The type of leukemia, household income, and social support are significant predictors of health utility scores of the FCs. Chronic lymphocytic leukemia, low socio-economic status, and low social support are associated with lower health utility scores of the FCs. FCs for leukemia patients have lower health utility scores than the local general population, as measured by the EQ-5D-3L. There is an immediate need to address the health concerns of FCs, who play an important role in the Chinese health care system.

27 February 2021 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
XZXueyun Zeng
Xueyun Zeng
MSMingjie Sui
Mingjie Sui
RLRui Liu
Rui Liu
XQXinyu Qian
Xinyu Qian
WLWenfeng Li
Wenfeng Li
NLNan Luo
Nan Luo
Objectives: This study aimed to assess the health utility of leukemia patients in China using the EQ-5D-5L, compare it with the population norms, and identify the potential factors associated with health utility. Methods: A hospital based cross-sectional survey was conducted in three tertiary hospitals from July 2015 to February 2016. A total of 186 patients with leukemia completed the EQ-5D-5L and their health utility scores were calculated using the Chinese value set. EQ-5D-5L utility and dimensions scores of leukemia patients were compared with China’s population norms using Kruskal–Wallis test and chi square test. Potential factors associated with health utility were identified using Tobit regression. Results: The mean EQ-5D-5L utility scores of patients with leukemia, grouped by either gender or age, were significantly lower than those of the general population (p < 0.001). The same results were found for individual dimensions of EQ-5D-5L, where leukemia patients reported more health problems than the general population (p < 0.001). The utility score of leukemia patients was found to be significantly related to medical insurance, religious belief, comorbidities, social support and ECOG performance status. Conclusion: This study indicated that leukemia patients have worse health status compared to the general population of China and that multiple factors affect the health utility of the patients. The utility scores reported in this study could be useful in future cost-utility analysis.

7 December 2023 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
HZHuan Zhang
Huan Zhang
BLBo Liu
Bo Liu
WGWen Gu
Wen Gu
YCYiyin Cao
Yiyin Cao
JXJuan Xu
Juan Xu
NLNan Luo
Nan Luo

12 January 2025 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
YTYuchun Tao
Yuchun Tao
YCYiyin Cao
Yiyin Cao
LXLijun Xu
Lijun Xu
JSJiaxuan Shi
Jiaxuan Shi
LLLei Leng
Lei Leng
WHWeidong Huang
Weidong Huang
Given the recent update of SF-6Dv2, detailed data on utility scores for cancer patients by cancer type remain scarce in China and other regions, which limits the precision of cost-utility analyses (CUA) in cancer interventions. The aim of the study was to systematically evaluate utility scores of six common cancers in China measured using SF-6Dv2, and identify the potential factors associated with utility scores. A hospital-based cross-sectional survey was conducted from August 2022 to December 2023. It recruited 896 cancer patients from three tertiary hospitals in China, including 270 with lung cancer, 96 with stomach cancer, 88 with liver cancer, 71 with oesophagus cancer, 142 with colorectum cancer, and 160 with breast cancer. The validated Simplified Chinese version of the SF-6Dv2 was used to calculate utilities based on the Chinese value set, and the utility values were described using the mean and standard deviation (SD). Participants’ socio-demographic, behavioral and clinical characteristics were also obtained from the survey. Univariate and multivariate linear regression models were performed to explore the impact of these three categories of characteristics on utility scores derived from SF-6Dv2 for the total cancer patients and each cancer group. The mean utility score was 0.66 (SD = 0.26) for the total cancer sample, 0.66 (SD = 0.25) for lung cancer, 0.75 (SD = 0.23) for stomach cancer, 0.69 (SD = 0.24) for liver cancer, 0.69 (SD = 0.24) for oesophagus cancer, 0.65 (SD = 0.31) for colorectum cancer, and 0.57 (SD = 0.24) for breast cancer. Multivariate linear regression analysis indicated that patients who were older, from larger families, under greater economic pressures, undergoing fewer health examinations, smoking, and in advanced cancer stages had lower utility scores in the total cancer sample (p<0.05), with variations observed across different cancer types. This study is one of the first to apply the SF-6Dv2 to a heterogeneous group of cancer patients, providing evidence for conducting CUA with SF-6Dv2 across six common cancers in China. In addition, the study provides a basis for improving interventions for different cancer types.